|
NCAPD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48309999999474E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.958000E-04 |
| Normal-vs-Stage2 |
4.856300E-02 |
| Normal-vs-Stage3 |
1.67986999999314E-05 |
| Normal-vs-Stage4 |
1.379830E-03 |
| Stage1-vs-Stage2 |
5.715200E-01 |
| Stage1-vs-Stage3 |
1.268590E-01 |
| Stage1-vs-Stage4 |
5.888600E-01 |
| Stage2-vs-Stage3 |
1.595630E-01 |
| Stage2-vs-Stage4 |
4.349600E-01 |
| Stage3-vs-Stage4 |
5.856000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.29010000000796E-05 |
| Normal-vs-AfricanAmerican |
1.554240E-01 |
| Normal-vs-Asian |
3.620800E-03 |
| Caucasian-vs-AfricanAmerican |
2.313200E-01 |
| Caucasian-vs-Asian |
7.859000E-01 |
| AfricanAmerican-vs-Asian |
4.109000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10649999999868E-05 |
| Normal-vs-Female |
1.218780E-04 |
| Male-vs-Female |
2.105200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.189900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.63749999999974E-05 |
| Normal-vs-Age(61-80Yrs) |
1.602800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.198800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.035000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.858800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.872000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.684600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.257000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.866200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.328200E-01 |
| Classical-VS-Follicular |
4.518600E-01 |
| Classical-VS-Other |
5.374600E-01 |
| Classical-VS-Normal |
2.353900E-04 |
| Tall-VS-Follicular |
1.076350E-01 |
| Tall-VS-Other |
9.977600E-01 |
| Tall-VS-Normal |
1.200920E-04 |
| Follicular-VS-Other |
2.438400E-01 |
| Follicular-VS-Normal |
2.158500E-02 |
| Other-VS-Normal |
1.803560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.825600E-04 |
| Normal-vs-N1 |
3.02450000044807E-07 |
| N0-vs-N1 |
1.808390E-02 |
|
|
